In 2021, Mindbloom was recognized by Built In as one of the "50 Best Remote-First Companies to Work For in 2021."
Mindbloom was joined by remote-first tech giants Twitter, Dropbox, and Slack, and along with Hims/Hers is one of few healthcare brands recognized by Built In in the remote-first category.
“Built In’s editorial teams have hand-selected the 50 Best Remote-First Companies to Work For. All have made long-term commitments to hiring and supporting remote employees, and we think they have the perks, culture and organizational capacity to allow all workers’ careers to flourish, regardless of location,” Built In mentions in their announcement.
Mindbloom has been a remote-first company since its inception in 2019. After piloting clinical services with a physical clinic in NYC, Mindbloom quickly adapted to the impact of COVID-19 in 2020 by offering clients fully virtual, at-home psychedelic therapy.
“Being a remote-first company, both as an employer and as a client-facing service, helps us increase access to psychedelic therapy for people who otherwise wouldn't be able to obtain it. The cherry on top is working with a phenomenal group of people around the world who are super mission-driven to transform people's lives and transform the world,” Georgette Monserrat, People Lead at Mindbloom, says, “I'm psyched to be part of such a progressive, trail-blazing company working in the cutting edge field of psychedelic telemedicine.”
If you’re interested in joining Mindbloom, a leader in remote-first psychedelic medicine and healthcare, check our Careers page for opportunities.
Want to Transform Lives?
Mindbloom is a remote-first company which has helped thousands of clients reach new levels of wellbeing. Browse our many open roles!
This article is for informational purposes only and is not intended to be a substitute for professional medical advice. Always talk to your doctor about the risks and benefits of any treatment. If you are in a life-threatening situation, call the National Suicide Prevention Line at +1 (800) 273-8255, call 911, or go to the nearest emergency room.
Important FDA Safety Information
Ketamine is not FDA-approved for the treatment of depression or anxiety. Learn more about off-label uses here.
Side effects of ketamine treatment may include: altered sense of time, anxiety, blurred vision, diminished ability to see/hear/feel, dry mouth, elevated blood pressure or heart rate, elevated intraocular or intracranial pressure, excitability, loss of appetite, mental confusion, nausea/vomiting, nystagmus (rapid eye movements), restlessness, slurred speech, synesthesia (a mingling of the senses).
Do not proceed with ketamine treatment if any of the following apply to you:
- Allergic to ketamine
- Symptoms of psychosis or mania
- Uncontrolled high blood pressure
- CHF or other serious heart problem
- Severe breathing problem
- History of elevated intraocular or intracranial pressure
- History of hyperthyroidism
- Other serious medical illness
- Pregnant, nursing, or trying to become pregnant
Ketamine has been reported to produce issues including, but not limited to, those listed below. However, lasting adverse side-effects are rare when medical protocols are carefully followed.
While ketamine has not been shown to be physically addictive, it has been shown to cause moderate psychological dependency in some recreational users.
- In rare cases, frequent, heavy users have reported increased frequency of urination, urinary incontinence, pain urinating, passing blood in the urine, or reduced bladder size
- Ketamine may worsen problems in people with schizophrenia, severe personality disorders, or other serious mental disorders.
- Users with a personal or family history of psychosis should be cautious using any psychoactive substance, including ketamine, and discuss potential risks with your MindBloom clinician before proceeding with treatment.
- The dissociative effects of ketamine may increase patient vulnerability and the risk of accidents.
To promote positive outcomes and ensure safety, follow these ketamine treatment guidelines:
- Do not operate a vehicle (e.g., car, motorcycle, bicycle) or heavy machinery following treatment until you’ve had a full night of sleep
- Refrain from taking benzodiazepines or stimulants for 24 hours prior to treatment
- Continue to take antihypertensive medication as prescribed
- Avoid hangovers or alcohol intake
- Refrain from consuming solid foods within 3 hours prior to treatment and liquids within 1 hour prior to treatment
- Ketamine treatment should never be conducted without a monitor present to ensure your safety